BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1409722)

  • 1. A phorbol ester response element within the human T-cell receptor beta-chain enhancer.
    Prosser HM; Wotton D; Gegonne A; Ghysdael J; Wang S; Speck NA; Owen MJ
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9934-8. PubMed ID: 1409722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human T cell receptor beta gene expression by Ets-1.
    Wotton D; Prosser HM; Owen MJ
    Leukemia; 1993 Aug; 7 Suppl 2():S55-60. PubMed ID: 8361234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
    Sun W; Graves BJ; Speck NA
    J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative binding of Ets-1 and core binding factor to DNA.
    Wotton D; Ghysdael J; Wang S; Speck NA; Owen MJ
    Mol Cell Biol; 1994 Jan; 14(1):840-50. PubMed ID: 8264651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro.
    Mayall TP; Sheridan PL; Montminy MR; Jones KA
    Genes Dev; 1997 Apr; 11(7):887-99. PubMed ID: 9106660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer.
    Ho IC; Bhat NK; Gottschalk LR; Lindsten T; Thompson CB; Papas TS; Leiden JM
    Science; 1990 Nov; 250(4982):814-8. PubMed ID: 2237431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions.
    Giese K; Kingsley C; Kirshner JR; Grosschedl R
    Genes Dev; 1995 Apr; 9(8):995-1008. PubMed ID: 7774816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways.
    Howard PW; Maurer RA
    J Biol Chem; 1995 Sep; 270(36):20930-6. PubMed ID: 7673116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
    Gunther CV; Graves BJ
    Mol Cell Biol; 1994 Nov; 14(11):7569-80. PubMed ID: 7935472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
    Cheng YH; Handwerger S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products.
    Lin JX; Bhat NK; John S; Queale WS; Leonard WJ
    Mol Cell Biol; 1993 Oct; 13(10):6201-10. PubMed ID: 8413220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and analysis of the proximal Janus kinase 3 promoter.
    Aringer M; Hofmann SR; Frucht DM; Chen M; Centola M; Morinobu A; Visconti R; Kastner DL; Smolen JS; O'Shea JJ
    J Immunol; 2003 Jun; 170(12):6057-64. PubMed ID: 12794134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
    Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
    Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression.
    Lemarchandel V; Ghysdael J; Mignotte V; Rahuel C; Roméo PH
    Mol Cell Biol; 1993 Jan; 13(1):668-76. PubMed ID: 8417360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.
    Sheridan PL; Sheline CT; Cannon K; Voz ML; Pazin MJ; Kadonaga JT; Jones KA
    Genes Dev; 1995 Sep; 9(17):2090-104. PubMed ID: 7657162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
    Zaiman AL; Nieves A; Lenz J
    J Virol; 1998 Apr; 72(4):3129-37. PubMed ID: 9525638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.